SURI
SURI
About Simplify Propel Opportunities ETF
The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation. The fund is sub-advised by Propel, which uses its deep scientific and commercial...
About Simplify Propel Opportunities ETF
The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation. The fund is sub-advised by Propel, which uses its deep scientific and commercial...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 PAGP | Plains GP Holdings, L.P. | 40.24% | 1.27M | $29.72M |
 MIST | Milestone Pharmaceuticals Inc. | 9.21% | 3.35M | $6.80M |
 ACHV | Achieve Life Sciences, Inc. | 5.79% | 1.18M | $4.28M |
 PHAT | Phathom Pharmaceuticals, Inc. | 4.28% | 249.27K | $3.16M |
 DCTH | Delcath Systems, Inc. | 3.85% | 261.13K | $2.84M |
 ABEO | Abeona Therapeutics Inc. | 3.52% | 500.34K | $2.60M |
 CLDX | Celldex Therapeutics, Inc. | 2.66% | 59.04K | $1.97M |
 OCS | Oculis Holding AG | 2.49% | 66.67K | $1.84M |
 CORT | Corcept Therapeutics Incorporated | 2.23% | 37.76K | $1.65M |
 LONA | LeonaBio, Inc. | 1.83% | 149.28K | $1.35M |
 KYTX | Kyverna Therapeutics, Inc. | 1.80% | 142.39K | $1.33M |
 IVA | Inventiva S.A. | 1.70% | 227.92K | $1.26M |
 OBIO | Orchestra BioMed Holdings, Inc. | 1.34% | 219.39K | $989.43K |
 ZVRA | Zevra Therapeutics, Inc. | 1.32% | 96.25K | $993.26K |
 AQST | Aquestive Therapeutics, Inc. | 1.32% | 234.28K | $972.26K |
 CMPS | COMPASS Pathways plc | 1.24% | 159.05K | $914.55K |
 VOR | Vor Biopharma Inc. | 1.11% | 53.51K | $834.76K |
 EYPT | EyePoint Pharmaceuticals, Inc. | 1.04% | 53.53K | $767.56K |
 SABS | SAB Biotherapeutics, Inc. | 0.98% | 187.23K | $722.71K |
 PALI | Palisade Bio, Inc. | 0.98% | 350.00K | $721.00K |
SECTOR HOLDINGS
Healthcare
EnergyASSET ALLOCATION BY REGION
United States
Canada
Switzerland
France
United KingdomSECTOR HOLDINGS
Healthcare EnergyASSET ALLOCATION BY REGION
United States Canada Switzerland France United KingdomHoldings (Top 20)
PAGP
Plains GP Holdings, L.P.
MIST
Milestone Pharmaceuticals Inc.
ACHV
Achieve Life Sciences, Inc.
PHAT
Phathom Pharmaceuticals, Inc.
DCTH
Delcath Systems, Inc.
ABEO
Abeona Therapeutics Inc.
CLDX
Celldex Therapeutics, Inc.
OCS
Oculis Holding AG
CORT
Corcept Therapeutics Incorporated
LONA
LeonaBio, Inc.
KYTX
Kyverna Therapeutics, Inc.
IVA
Inventiva S.A.
OBIO
Orchestra BioMed Holdings, Inc.
ZVRA
Zevra Therapeutics, Inc.
AQST
Aquestive Therapeutics, Inc.
CMPS
COMPASS Pathways plc
VOR
Vor Biopharma Inc.
EYPT
EyePoint Pharmaceuticals, Inc.
SABS
SAB Biotherapeutics, Inc.
PALI
Palisade Bio, Inc.